Prolastin-c liquid, human 1000MG/vial 13533-0705-01

Ended Awarded Last action

Contract number
36C26023F0005
Awardee
Awarding agency
Obligated
$502,921

Award facts

Contract value 100% obligated
$502,920.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Los Angeles, CA 90032, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 -$35,079
Supplemental Agreement for work within scope P00001 $90,000
Original award $448,000

About this award

This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awards Grifols USA LLC $502,920.80 to supply Prolastin-C Liquid, Human 1000mg/vial under the firm fixed price contract. The order is placed against Grifols' Pharmaceuticals and Drugs Schedule contract with the General Services Administration and requires delivery by September 30, 2023. No set-aside provision was applied to this order. Grifols will provide the specialized drug Prolastin-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, to support healthcare programs within VISN 20 facilities located in Los Angeles, California. Through indefinite delivery contracts and its Pharmaceuticals and Drugs schedule, Grifols regularly supplies this and other specialized drugs to various Veterans Affairs networks and agencies to meet ongoing patient needs.

Quick answers

Who was awarded contract 36C26023F0005?

36C26023F0005 was awarded to Grifols USA LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2022.

How much is contract 36C26023F0005 worth?

The government has obligated $502,921 on 36C26023F0005.

Is contract 36C26023F0005 an order under another contract?

Yes. 36C26023F0005 is a delivery order under 36F79722D0090, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26023F0005 competed?

The extent of competition for 36C26023F0005 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award